{"gene":"SHBG","run_date":"2026-04-28T20:42:07","timeline":{"discoveries":[{"year":1975,"finding":"Androgen-binding protein (ABP/SHBG) is produced by Sertoli cells in the testis, not by Leydig cells or germ cells; FSH stimulates its production and it is transported to the epididymis via efferent duct fluid.","method":"Testicular fractionation (tubule vs. interstitial preparations), efferent duct fluid vs. lymph measurements, gamma irradiation to ablate germ cells, hypophysectomy followed by FSH rescue","journal":"Molecular and cellular endocrinology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal in vivo experiments replicated across conditions","pmids":["1126559"],"is_preprint":false},{"year":1981,"finding":"SHBG (TeBG) functions as an androgen transport and carrier protein in plasma, and as androgen-binding protein (ABP) in the seminiferous tubule/epididymis compartment, with both serving to regulate androgen secretion, transport, and cellular absorption.","method":"Review of physical characterization studies (binding kinetics, gel filtration, sedimentation) and hormonal regulation experiments","journal":"Archives of andrology","confidence":"Medium","confidence_rationale":"Tier 3 — review synthesizing multiple binding and physicochemical characterization studies","pmids":["7025773"],"is_preprint":false},{"year":1988,"finding":"TeBG (SHBG)-bound testosterone and estradiol are efficiently cleared across the blood-tubular barrier of the testis and prostate cell membrane in vivo, indicating that TeBG-bound sex steroids (not just free hormone) are bioavailable to Sertoli and prostate cells; extravascular extraction of radiolabeled TeBG was 73–92% in testis and prostate respectively.","method":"In vivo arterial bolus injection of radiolabeled testosterone, estradiol, and TeBG in anesthetized rats; tissue extraction quantification","journal":"The Journal of clinical endocrinology and metabolism","confidence":"High","confidence_rationale":"Tier 1/2 — direct in vivo quantitative influx measurements with multiple tracers","pmids":["3379140"],"is_preprint":false},{"year":1991,"finding":"SHBG inhibits uptake of DHT into prostate carcinoma cells in a binding-capacity-dependent manner, but also stimulates DNA synthesis (thymidine incorporation) in these cells via a specific high-affinity cell membrane receptor for SHBG; this growth effect is enhanced by testosterone and abolished when SHBG is saturated with DHT. SHBG mRNA (1.9 and 2.8 kb) is expressed endogenously in prostate carcinoma cell lines.","method":"Radiolabeled DHT uptake assays, [3H]thymidine incorporation, Northern blot, radioligand binding (cell membrane receptor identification)","journal":"The Journal of steroid biochemistry and molecular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (binding, uptake, proliferation, mRNA) in a single study","pmids":["1958578"],"is_preprint":false},{"year":1991,"finding":"TeBG (SHBG) undergoes receptor-mediated endocytosis in human MCF-7 breast cancer cells: it binds to the plasma membrane, enters receptosomes, and traffics through multivesicular endosomes to lysosomes in the Golgi zone; uptake is temperature-dependent, saturable, and competable with unlabeled TeBG.","method":"Radiolabeled TeBG uptake assays, electron microscopy with TeBG-gold complexes, pronase surface release experiments, subcellular fractionation with lysosomal marker","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1 — electron microscopy with gold conjugates plus fractionation, multiple orthogonal methods in one study","pmids":["1675988"],"is_preprint":false},{"year":1992,"finding":"SHBG is a homodimer; the steroid-binding site is located at the interface between the two subunits. Dissociation in urea and renaturation reconstitutes dimers with normal steroid-binding affinity. A human-rabbit hybrid dimer demonstrates that only one face of the dimer determines specificity for estradiol binding, while the androgen-binding face is shared by both sides.","method":"Urea dissociation and renaturation, formation of human-rabbit hybrid dimers, radioligand binding (Kd determination for DHT and estradiol)","journal":"Protein science","confidence":"High","confidence_rationale":"Tier 1 — reconstitution of native function from denatured subunits plus hybrid dimer experiment, mechanistically definitive","pmids":["8976560"],"is_preprint":false},{"year":1995,"finding":"Sertoli cell-secreted ABP is endocytosed by germ cells via a clathrin-coated vesicle pathway; germ cells possess a single class of high-affinity binding sites for ABP (Kd ~0.78 nM for rat ABP, ~0.56 nM for human SHBG); internalized ABP stimulates secretion of specific spermatocyte proteins and, together with steroids, induces synthesis of new spermatocyte proteins.","method":"Radiolabeled ABP/SHBG binding and internalization, transmission electron microscopy, autoradiography, 2D-SDS-PAGE of secreted proteins, Scatchard analysis of membrane binding sites","journal":"The Journal of steroid biochemistry and molecular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (EM, autoradiography, binding kinetics, proteomic analysis) in one study","pmids":["7626507"],"is_preprint":false},{"year":1992,"finding":"SHBG binds to a specific, saturable, high-affinity receptor on rat testicular membranes (Kd 5×10⁻⁸ M at 37°C; capacity 30 pmol/mg protein); solubilization of the receptor increases binding capacity 5-fold and decreases affinity 10-fold; apparent molecular weight of the testicular SHBG receptor is ~174,000 Da.","method":"Radioligand binding to testicular membrane preparations, Scatchard analysis, gel filtration of solubilized receptor","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — systematic binding characterization in membrane fractions with multiple parameters; single lab","pmids":["1338724"],"is_preprint":false},{"year":1998,"finding":"The SHBG-like region of protein S (a structural homolog domain) is critical for its FV-dependent APC-cofactor activity in FVIIIa degradation; a protein S/Gas6 chimera in which the SHBG-like region was replaced by that of Gas6 lost FV-dependent APC-cofactor activity while retaining ~40–50% activity in FVa degradation.","method":"Recombinant chimeric protein construction and functional testing in plasma thrombin generation and FVIIIa degradation assays","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — domain-swap mutagenesis with direct functional reconstitution assays","pmids":["9738926"],"is_preprint":false},{"year":2004,"finding":"The D327N (Asp327Asn) polymorphism in SHBG exon 8 delays SHBG half-life and is associated with higher circulating SHBG levels; the pentanucleotide (TAAAA)n repeat in the SHBG 5' UTR influences SHBG transcription in vitro and affects SHBG serum concentrations in a repeat-length-dependent manner (fewer repeats → higher SHBG).","method":"RFLP genotyping for D327N, GeneScan for TAAAA repeats, multivariate analysis of serum SHBG levels, luciferase reporter assays (cited in text for in vitro transcription effect)","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — functional polymorphism data combined with population genetics; D327N half-life effect from prior studies cited","pmids":["14764814"],"is_preprint":false},{"year":2006,"finding":"SHBG interacts with a specific binding site on MCF-7 breast cancer cell membranes and activates a cAMP-dependent intracellular pathway that inhibits estradiol-mediated ERK activation and cell growth; cross-talk occurs at the MAP kinase level between the membrane-initiated SHBG pathway and the estradiol pathway.","method":"Cell membrane binding assays, cAMP measurement, ERK activation assays, cell proliferation/apoptosis assays in MCF-7 cells","journal":"Hormone and metabolic research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple signaling readouts in a single cell model; single lab","pmids":["16700004"],"is_preprint":false},{"year":2010,"finding":"Incompletely glycosylated (lacking O-linked oligosaccharides and with incomplete N-glycosylation) SHBG accumulates within the cytoplasm of proximal tubule epithelial cells and enhances androgen uptake and sustained androgen receptor nuclear localization, thereby amplifying androgen-dependent gene expression long after steroid withdrawal.","method":"Western blotting of cellular vs. secreted SHBG, radiolabeled DHT sequestration assays, luciferase androgen reporter assay, RT-qPCR of endogenous androgen-regulated genes, transcriptome profiling, immunofluorescence of androgen receptor localization in mouse PCT cell line expressing human SHBG transgene","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1/2 — multiple orthogonal methods (biochemical, reporter, transcriptomic, imaging) in a mechanistically defined cellular system","pmids":["21193555"],"is_preprint":false},{"year":2012,"finding":"TNFα reduces SHBG production in hepatocytes indirectly via NF-κB activation: NF-κB binds to the HNF-4α proximal promoter (which contains three NF-κB binding sites) and represses HNF-4α expression, which in turn reduces SHBG transcription. The human SHBG promoter itself is not directly regulated by NF-κB.","method":"Luciferase reporter assays with SHBG and HNF-4α promoter constructs, siRNA knockdown of NF-κB p65, p65 overexpression, chromatin immunoprecipitation (ChIP) for NF-κB binding to HNF-4α promoter in HepG2 cells","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1 — ChIP plus reporter assays plus siRNA/overexpression; multiple orthogonal mechanistic approaches in one study","pmids":["22301786"],"is_preprint":false},{"year":2014,"finding":"Adiponectin increases hepatic SHBG production via AMPK activation, which reduces hepatic lipid content (decreasing ACC-driven lipogenesis, increasing ACOX/CPTI-driven fatty acid oxidation) and thereby increases HNF-4α levels; HNF-4α silencing blocks adiponectin-induced SHBG upregulation.","method":"HepG2 cell treatment with adiponectin, AMPK inhibition assays, siRNA knockdown of HNF-4α, lipogenesis/fatty acid oxidation enzyme mRNA/protein measurement, triglyceride and FFA quantification, correlation with human liver biopsies","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1/2 — siRNA rescue experiments plus pharmacological inhibition plus human liver biopsy correlation; multiple orthogonal approaches","pmids":["24828613"],"is_preprint":false},{"year":2014,"finding":"The SHBG-like domain (and specifically its laminin G-type 1 subunit, residues Ser283–Val459) of protein S is required for binding to TFPI and enhancing TFPI-mediated inhibition of factor Xa; free protein S (not C4BP-bound) is needed for TFPI cofactor function.","method":"Domain-swap chimera screening (44 protein S variants), thrombin generation assay, FXa inhibition assays, surface plasmon resonance binding of protein S to TFPI","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 — comprehensive domain-swap mutagenesis with SPR and functional assays; mechanistically definitive","pmids":["24740810"],"is_preprint":false},{"year":2014,"finding":"Eight naturally occurring nonsynonymous SNPs in the N-terminal laminin G-like domain of SHBG alter its production or biochemical properties: O-linked glycosylation at Thr7 is disrupted (T7N), abnormal N-glycosylation limits secretion (G195E), three mutants (R135C, L165M, E176K) bind estradiol with abnormally high affinity, R135C has increased fibulin-2 interaction, two dimer-interface mutants (R123H, R123C) reduce DHT affinity while increasing relative estradiol affinity, and T48I is defective in calcium binding leading to dimerization defects and reduced steroid affinity (all restored by calcium).","method":"Site-directed mutagenesis, HepG2 cell expression and secretion assays, radioligand steroid-binding assays, calcium chelation/supplementation experiments, fibulin-2 binding assays","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with multiple biochemical functional readouts; single comprehensive study","pmids":["24892637"],"is_preprint":false},{"year":2017,"finding":"Resveratrol increases hepatic SHBG production specifically through human constitutive androstane receptor (CAR), which binds to a direct repeat 1 (DR1) nuclear hormone receptor element in the human SHBG proximal promoter; this was confirmed in humanized SHBG/CAR transgenic mice and correlates with CAR mRNA in human liver biopsies.","method":"Chromatin immunoprecipitation (ChIP) for CAR binding to SHBG promoter DR1 element, luciferase reporter assays, resveratrol treatment of HepG2 cells, humanized transgenic mouse experiments, human liver biopsy correlation","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 — ChIP plus reporter assays plus in vivo transgenic validation; multiple orthogonal methods","pmids":["28947831"],"is_preprint":false},{"year":2004,"finding":"SHBG mRNA and protein are expressed locally in human granulosa-lutein cells (GLC) of the ovary, demonstrating that SHBG is produced in this tissue beyond the liver and may have a paracrine role in follicular physiology.","method":"Immunohistochemistry on human GLC, RT-PCR for full-length SHBG mRNA in cultured and uncultured cells","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 3 — localization by IHC and RT-PCR; single lab without functional mechanistic follow-up","pmids":["15149727"],"is_preprint":false},{"year":2006,"finding":"SHBG mRNA and protein are expressed in human cardiac myocytes (in dilated cardiomyopathy biopsies), confirmed by immunocytochemistry on semithin sections, in situ hybridization, and SELDI-TOF mass spectrometry of affinity-purified myocardial extracts, suggesting a local paracrine role for SHBG in regulating steroid bioavailability in the heart.","method":"Immunocytochemistry, in situ hybridization, SELDI-TOF mass spectrometry","journal":"Hormone and metabolic research","confidence":"Medium","confidence_rationale":"Tier 2 — three orthogonal detection methods confirm expression; limited functional mechanistic follow-up","pmids":["16700002"],"is_preprint":false},{"year":2021,"finding":"Exogenous SHBG protects palmitate-treated hepatocytes against ER stress by reducing expression of IRE1α, ATF6, CHOP, and BIP, and also regulates lipolytic gene expression in liver tissue ex vivo.","method":"Palmitate-treated HepG2 cells and ex vivo liver tissue culture with exogenous SHBG (50–100 nM), western blotting and RT-qPCR for ER stress markers","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro and ex vivo experiments with multiple molecular markers; single lab, mechanistic pathway not fully defined","pmids":["33808055"],"is_preprint":false},{"year":2017,"finding":"SHBG binding capacity for testosterone and estradiol differs between sexes and obesity status: in men testosterone occupies most SHBG binding sites whereas estradiol binding is much lower; morbid obesity reduces SHBG levels and consequently testosterone (but not estradiol) binding, suggesting SHBG is a mixture of at least two functionally distinct hormone-binding globulins with different affinities for the two steroids.","method":"Western blotting of plasma SHBG protein, tritium-labeled testosterone and estradiol specific binding assays, ELISA for hormones in plasma from normal-weight and obese men and women","journal":"European journal of endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding assays with two steroid substrates across subject groups; single lab","pmids":["28077498"],"is_preprint":false}],"current_model":"SHBG is a homodimeric glycoprotein (with the steroid-binding site formed at the dimer interface) produced primarily by hepatocytes under transcriptional control of HNF-4α (itself regulated by AMPK/adiponectin signaling, NF-κB/TNFα signaling, and the nuclear receptor CAR/resveratrol pathway) and by Sertoli cells in response to FSH; it circulates as a high-affinity carrier for androgens and estrogens, regulates their bioavailability, is taken into cells via a specific membrane receptor through receptor-mediated endocytosis, and—particularly in its incompletely glycosylated intracellular form—can sustain androgen receptor nuclear localization and gene activation; additionally, SHBG activates a cAMP-dependent membrane-initiated signaling cascade in estrogen-responsive cells that cross-talks with ERK to antagonize estradiol-driven proliferation."},"narrative":{"teleology":[{"year":1975,"claim":"Identifying SHBG/ABP as a Sertoli cell product under FSH control established that SHBG is not merely a passive plasma binder but an actively regulated secretory protein with a defined cellular origin in the testis.","evidence":"Testicular fractionation, hypophysectomy with FSH rescue, efferent duct fluid measurements in rat","pmids":["1126559"],"confidence":"High","gaps":["Mechanism of FSH-stimulated transcription not defined","Sertoli cell SHBG promoter elements unknown at this stage"]},{"year":1988,"claim":"Demonstrating that SHBG-bound steroids are efficiently extracted by testis and prostate in vivo overturned the free-hormone hypothesis for these tissues, showing SHBG itself facilitates steroid delivery.","evidence":"Arterial bolus injection of radiolabeled TeBG/steroids with tissue extraction quantification in anesthetized rats","pmids":["3379140"],"confidence":"High","gaps":["Identity of the membrane receptor mediating SHBG-steroid uptake not determined","Mechanism of transcapillary transport unclear"]},{"year":1991,"claim":"Discovery of a specific high-affinity membrane receptor for SHBG on prostate and breast cancer cells, and demonstration of receptor-mediated endocytosis through clathrin-coated vesicles to lysosomes, established that SHBG signals and traffics as a ligand rather than acting solely as an extracellular carrier.","evidence":"Radioligand binding, electron microscopy with gold-conjugated TeBG, thymidine incorporation in prostate carcinoma cells; saturable endocytosis in MCF-7 cells","pmids":["1958578","1675988"],"confidence":"High","gaps":["Molecular identity of the SHBG membrane receptor remains unknown","Downstream signaling mechanism not yet characterized"]},{"year":1992,"claim":"Establishing that SHBG functions as a homodimer with the steroid-binding site at the dimer interface defined the structural basis for steroid recognition and explained species-specific ligand selectivity.","evidence":"Urea dissociation/renaturation, human-rabbit hybrid dimer formation with radioligand binding","pmids":["8976560"],"confidence":"High","gaps":["Atomic-resolution crystal structure not yet available at this point","Role of calcium in dimerization not yet recognized"]},{"year":1995,"claim":"Showing that germ cells endocytose Sertoli-derived ABP/SHBG via clathrin-coated pits and that internalized ABP alters spermatocyte protein secretion demonstrated a paracrine signaling role for SHBG within the seminiferous epithelium.","evidence":"Radiolabeled ABP binding/internalization, TEM, 2D-SDS-PAGE of secreted spermatocyte proteins","pmids":["7626507"],"confidence":"High","gaps":["Intracellular fate of internalized ABP in germ cells not fully tracked","Downstream signaling cascade in germ cells not identified"]},{"year":2006,"claim":"Identifying that membrane-bound SHBG activates a cAMP pathway that cross-talks with ERK to oppose estradiol-driven proliferation revealed an active anti-proliferative signaling function independent of simple steroid sequestration.","evidence":"cAMP measurement, ERK activation assays, proliferation/apoptosis assays in MCF-7 breast cancer cells","pmids":["16700004"],"confidence":"Medium","gaps":["Identity of the G-protein or receptor coupling SHBG to cAMP unknown","Relevance in non-breast-cancer estrogen-responsive tissues not tested","Single lab finding"]},{"year":2010,"claim":"Demonstrating that incompletely glycosylated intracellular SHBG sequesters androgens and sustains androgen receptor nuclear localization established a cell-autonomous amplification mechanism for androgen signaling distinct from extracellular carrier function.","evidence":"Radiolabeled DHT sequestration, androgen-responsive reporter and endogenous gene assays, immunofluorescence of AR localization in mouse PCT cells expressing human SHBG transgene","pmids":["21193555"],"confidence":"High","gaps":["Whether intracellular SHBG acts similarly in prostate cancer cells in vivo is untested","Glycosylation site(s) responsible for intracellular retention not mapped"]},{"year":2012,"claim":"Elucidating that TNFα suppresses SHBG via NF-κB-mediated repression of HNF-4α (not direct SHBG promoter targeting) explained how inflammation reduces circulating SHBG and linked metabolic syndrome to sex steroid bioavailability.","evidence":"ChIP for NF-κB on HNF-4α promoter, siRNA knockdown and p65 overexpression, luciferase reporters in HepG2 cells","pmids":["22301786"],"confidence":"High","gaps":["Whether other inflammatory cytokines use the same HNF-4α-dependent route is unknown","In vivo validation in hepatocyte-specific knockout models lacking"]},{"year":2014,"claim":"Identifying adiponectin/AMPK as an upstream activator of SHBG via HNF-4α through reduced hepatic lipid content connected energy-sensing pathways to sex steroid regulation, while comprehensive mutagenesis of naturally occurring SHBG variants revealed how specific residues govern glycosylation, calcium-dependent dimerization, and differential steroid affinity.","evidence":"Adiponectin treatment of HepG2 cells with AMPK inhibition and HNF-4α siRNA; site-directed mutagenesis of eight SNPs with binding, secretion, and calcium-dependence assays","pmids":["24828613","24892637"],"confidence":"High","gaps":["Structural basis for how hepatic lipid content controls HNF-4α levels is incompletely defined","Population-level functional impact of rare SHBG missense variants on disease risk not established"]},{"year":2017,"claim":"Demonstrating that the nuclear receptor CAR binds a DR1 element in the SHBG promoter and mediates resveratrol-induced SHBG expression identified a druggable transcriptional regulator of SHBG and was validated in humanized transgenic mice.","evidence":"ChIP for CAR on SHBG promoter, luciferase reporters, resveratrol treatment in HepG2 cells and humanized SHBG/CAR transgenic mice, human liver biopsy correlation","pmids":["28947831"],"confidence":"High","gaps":["Whether CAR agonists beyond resveratrol regulate SHBG in humans is untested","Relative contribution of CAR vs. HNF-4α to basal SHBG expression not quantified"]},{"year":null,"claim":"The molecular identity of the membrane receptor that mediates SHBG binding, endocytosis, and cAMP signaling remains unknown, preventing a complete mechanistic model of SHBG's cell-surface signaling and steroid-delivery functions.","evidence":"","pmids":[],"confidence":"Low","gaps":["SHBG membrane receptor gene not cloned or identified","Structural basis of SHBG-receptor interaction undefined","Whether intracellular SHBG and membrane signaling converge on shared downstream targets is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[1,5,15,20]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[0,1,2,6]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[3,10]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,1,2,5,20]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,4,10]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[11]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,10,11]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[12,13,16]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,2,6]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[13,19]}],"complexes":["SHBG homodimer"],"partners":["HNF4A","NR1I3","FBLN2"],"other_free_text":[]},"mechanistic_narrative":"SHBG is a homodimeric glycoprotein that serves as the principal plasma carrier for androgens and estrogens, regulating their bioavailability to target tissues through both passive transport and active receptor-mediated endocytosis. The steroid-binding site resides at the dimer interface, with calcium required for proper dimerization and distinct binding determinants for androgens versus estradiol [PMID:8976560, PMID:24892637]. Hepatic SHBG transcription is driven by HNF-4α and modulated by AMPK/adiponectin signaling, TNFα/NF-κB-mediated HNF-4α repression, and the nuclear receptor CAR, while Sertoli cells produce it under FSH control for androgen delivery to germ cells [PMID:1126559, PMID:24828613, PMID:22301786, PMID:28947831]. Beyond passive steroid sequestration, SHBG activates a cAMP-dependent membrane signaling pathway that antagonizes estradiol-driven ERK activation and cell proliferation, and incompletely glycosylated intracellular SHBG sustains androgen receptor nuclear localization and amplifies androgen-dependent gene expression [PMID:16700004, PMID:21193555]."},"prefetch_data":{"uniprot":{"accession":"P04278","full_name":"Sex hormone-binding globulin","aliases":["Sex steroid-binding protein","SBP","Testis-specific androgen-binding protein","ABP","Testosterone-estradiol-binding globulin","TeBG","Testosterone-estrogen-binding globulin"],"length_aa":402,"mass_kda":43.8,"function":"Functions as an androgen transport protein, but may also be involved in receptor mediated processes. Each dimer binds one molecule of steroid. Specific for 5-alpha-dihydrotestosterone, testosterone, and 17-beta-estradiol. Regulates the plasma metabolic clearance rate of steroid hormones by controlling their plasma concentration","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P04278/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SHBG","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SHBG","total_profiled":1310},"omim":[{"mim_id":"615723","title":"PREMATURE OVARIAN FAILURE 8; POF8","url":"https://www.omim.org/entry/615723"},{"mim_id":"615597","title":"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X","url":"https://www.omim.org/entry/615597"},{"mim_id":"614450","title":"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6","url":"https://www.omim.org/entry/614450"},{"mim_id":"613498","title":"SEX HORMONE-BINDING GLOBULIN CIRCULATING LEVEL QUANTITATIVE TRAIT LOCUS; SXGQTL1","url":"https://www.omim.org/entry/613498"},{"mim_id":"608605","title":"OLIGOSACCHARYLTRANSFERASE COMPLEX, CATALYTIC SUBUNIT STT3B; STT3B","url":"https://www.omim.org/entry/608605"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"liver","ntpm":59.3}],"url":"https://www.proteinatlas.org/search/SHBG"},"hgnc":{"alias_symbol":["ABP","TEBG","MGC126834","MGC138391"],"prev_symbol":[]},"alphafold":{"accession":"P04278","domains":[{"cath_id":"2.60.120.200","chopping":"46-215","consensus_level":"high","plddt":93.507,"start":46,"end":215},{"cath_id":"2.60.120.200","chopping":"223-392","consensus_level":"high","plddt":91.2356,"start":223,"end":392}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P04278","model_url":"https://alphafold.ebi.ac.uk/files/AF-P04278-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P04278-F1-predicted_aligned_error_v6.png","plddt_mean":85.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SHBG","jax_strain_url":"https://www.jax.org/strain/search?query=SHBG"},"sequence":{"accession":"P04278","fasta_url":"https://rest.uniprot.org/uniprotkb/P04278.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P04278/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P04278"}},"corpus_meta":[{"pmid":"2391361","id":"PMC_2391361","title":"Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring.","date":"1990","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/2391361","citation_count":471,"is_preprint":false},{"pmid":"9768844","id":"PMC_9768844","title":"Novel anchorage of GluR2/3 to the postsynaptic density by the AMPA receptor-binding protein ABP.","date":"1998","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/9768844","citation_count":309,"is_preprint":false},{"pmid":"16055064","id":"PMC_16055064","title":"PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking.","date":"2005","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/16055064","citation_count":187,"is_preprint":false},{"pmid":"19933169","id":"PMC_19933169","title":"Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19933169","citation_count":178,"is_preprint":false},{"pmid":"28584187","id":"PMC_28584187","title":"Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study.","date":"2017","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/28584187","citation_count":148,"is_preprint":false},{"pmid":"23762392","id":"PMC_23762392","title":"Detection of haplotypes associated with prenatal death in dairy cattle and identification of deleterious mutations in GART, SHBG and SLC37A2.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23762392","citation_count":121,"is_preprint":false},{"pmid":"10692483","id":"PMC_10692483","title":"Modulation of dopamine D(2) receptor signaling by actin-binding protein (ABP-280).","date":"2000","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10692483","citation_count":112,"is_preprint":false},{"pmid":"1126559","id":"PMC_1126559","title":"Sertoli cell origin of testicular androgen-binding protein (ABP).","date":"1975","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/1126559","citation_count":111,"is_preprint":false},{"pmid":"1310321","id":"PMC_1310321","title":"Targeted disruption of the ABP-120 gene leads to cells with altered motility.","date":"1992","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1310321","citation_count":109,"is_preprint":false},{"pmid":"12011465","id":"PMC_12011465","title":"Differential roles for NSF and GRIP/ABP in AMPA receptor cycling.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12011465","citation_count":108,"is_preprint":false},{"pmid":"14764814","id":"PMC_14764814","title":"Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women.","date":"2004","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/14764814","citation_count":94,"is_preprint":false},{"pmid":"19770023","id":"PMC_19770023","title":"Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer.","date":"2009","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19770023","citation_count":87,"is_preprint":false},{"pmid":"1701370","id":"PMC_1701370","title":"Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity.","date":"1990","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/1701370","citation_count":86,"is_preprint":false},{"pmid":"29880292","id":"PMC_29880292","title":"Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial.","date":"2018","source":"The Lancet. Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29880292","citation_count":79,"is_preprint":false},{"pmid":"27461107","id":"PMC_27461107","title":"Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab.","date":"2016","source":"BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/27461107","citation_count":76,"is_preprint":false},{"pmid":"24828613","id":"PMC_24828613","title":"Adiponectin upregulates SHBG production: molecular mechanisms and potential implications.","date":"2014","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24828613","citation_count":74,"is_preprint":false},{"pmid":"8370129","id":"PMC_8370129","title":"Circadian variation in serum free and non-SHBG-bound testosterone in normal men: measurements, and simulation using a mass action model.","date":"1993","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8370129","citation_count":74,"is_preprint":false},{"pmid":"16100394","id":"PMC_16100394","title":"Plant villin, lily P-135-ABP, possesses G-actin binding activity and accelerates the polymerization and depolymerization of actin in a Ca2+-sensitive manner.","date":"2005","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16100394","citation_count":61,"is_preprint":false},{"pmid":"8545277","id":"PMC_8545277","title":"Roles of estrogen and SHBG in prostate physiology.","date":"1996","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/8545277","citation_count":60,"is_preprint":false},{"pmid":"12883384","id":"PMC_12883384","title":"Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls.","date":"2003","source":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)","url":"https://pubmed.ncbi.nlm.nih.gov/12883384","citation_count":60,"is_preprint":false},{"pmid":"14581634","id":"PMC_14581634","title":"Plant 115-kDa actin-filament bundling protein, P-115-ABP, is a homologue of plant villin and is widely distributed in cells.","date":"2003","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14581634","citation_count":60,"is_preprint":false},{"pmid":"21239514","id":"PMC_21239514","title":"SHBG, sex hormones, and inflammatory markers in older women.","date":"2011","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21239514","citation_count":59,"is_preprint":false},{"pmid":"29553864","id":"PMC_29553864","title":"Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumab.","date":"2018","source":"mAbs","url":"https://pubmed.ncbi.nlm.nih.gov/29553864","citation_count":58,"is_preprint":false},{"pmid":"28565121","id":"PMC_28565121","title":"SALIVARY ANDROGEN-BINDING PROTEIN (ABP) MEDIATES SEXUAL ISOLATION IN MUS MUSCULUS.","date":"1997","source":"Evolution; international journal of organic evolution","url":"https://pubmed.ncbi.nlm.nih.gov/28565121","citation_count":57,"is_preprint":false},{"pmid":"22301786","id":"PMC_22301786","title":"Molecular Mechanism of TNFα-Induced Down-Regulation of SHBG Expression.","date":"2012","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/22301786","citation_count":54,"is_preprint":false},{"pmid":"29298529","id":"PMC_29298529","title":"SHBG expression is correlated with PI3K/AKT pathway activity in a cellular model of human insulin resistance.","date":"2018","source":"Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/29298529","citation_count":53,"is_preprint":false},{"pmid":"17189294","id":"PMC_17189294","title":"The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome.","date":"2006","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17189294","citation_count":53,"is_preprint":false},{"pmid":"21317201","id":"PMC_21317201","title":"Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.","date":"2011","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21317201","citation_count":52,"is_preprint":false},{"pmid":"2971509","id":"PMC_2971509","title":"Serum levels of 3-keto-desogestrel and SHBG during 12 cycles of treatment with 30 micrograms ethinylestradiol and 150 micrograms desogestrel.","date":"1988","source":"Contraception","url":"https://pubmed.ncbi.nlm.nih.gov/2971509","citation_count":52,"is_preprint":false},{"pmid":"1958578","id":"PMC_1958578","title":"Effects of sex hormone binding globulin (SHBG) on human prostatic carcinoma.","date":"1991","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1958578","citation_count":50,"is_preprint":false},{"pmid":"18829069","id":"PMC_18829069","title":"Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study.","date":"2008","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/18829069","citation_count":50,"is_preprint":false},{"pmid":"19064566","id":"PMC_19064566","title":"Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women.","date":"2008","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19064566","citation_count":49,"is_preprint":false},{"pmid":"1675988","id":"PMC_1675988","title":"Receptor-mediated endocytosis of an extracellular steroid-binding protein (TeBG) in MCF-7 human breast cancer cells.","date":"1991","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/1675988","citation_count":48,"is_preprint":false},{"pmid":"30617139","id":"PMC_30617139","title":"Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study.","date":"2019","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/30617139","citation_count":48,"is_preprint":false},{"pmid":"21252242","id":"PMC_21252242","title":"Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome.","date":"2011","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21252242","citation_count":47,"is_preprint":false},{"pmid":"3379140","id":"PMC_3379140","title":"Influx of testosterone-binding globulin (TeBG) and TeBG-bound sex steroid hormones into rat testis and prostate.","date":"1988","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/3379140","citation_count":47,"is_preprint":false},{"pmid":"3679643","id":"PMC_3679643","title":"Behaviour of testosterone, sex hormone binding globulin (SHBG), and cortisol before and after a triathlon competition.","date":"1987","source":"International journal of sports medicine","url":"https://pubmed.ncbi.nlm.nih.gov/3679643","citation_count":47,"is_preprint":false},{"pmid":"9738926","id":"PMC_9738926","title":"The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function.","date":"1998","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9738926","citation_count":44,"is_preprint":false},{"pmid":"3814697","id":"PMC_3814697","title":"Characteristics of a testosterone-estradiol binding globulin (TEBG) in goldfish serum.","date":"1986","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/3814697","citation_count":43,"is_preprint":false},{"pmid":"24740810","id":"PMC_24740810","title":"TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24740810","citation_count":43,"is_preprint":false},{"pmid":"29139641","id":"PMC_29139641","title":"Sex Hormone Binding Globulin (SHBG) as a Marker of Clinical Disorders.","date":"2016","source":"Collegium antropologicum","url":"https://pubmed.ncbi.nlm.nih.gov/29139641","citation_count":42,"is_preprint":false},{"pmid":"8971707","id":"PMC_8971707","title":"Identification and cellular localization of the actin-binding protein ABP-120 from Entamoeba histolytica.","date":"1996","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/8971707","citation_count":41,"is_preprint":false},{"pmid":"18681858","id":"PMC_18681858","title":"Polymorphisms of the SHBG gene contribute to the interindividual variation of sex steroid hormone blood levels in young, middle-aged and elderly men.","date":"2008","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/18681858","citation_count":41,"is_preprint":false},{"pmid":"20493915","id":"PMC_20493915","title":"A cationic amphiphilic peptide ABP-CM4 exhibits selective cytotoxicity against leukemia cells.","date":"2010","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/20493915","citation_count":40,"is_preprint":false},{"pmid":"16700004","id":"PMC_16700004","title":"Sex hormone-binding globulin (SHBG) and estradiol cross-talk in breast cancer cells.","date":"2006","source":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/16700004","citation_count":39,"is_preprint":false},{"pmid":"27422671","id":"PMC_27422671","title":"Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab.","date":"2016","source":"BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/27422671","citation_count":39,"is_preprint":false},{"pmid":"7626507","id":"PMC_7626507","title":"Endocytosis of androgen-binding protein (ABP) by spermatogenic cells.","date":"1995","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7626507","citation_count":38,"is_preprint":false},{"pmid":"23001781","id":"PMC_23001781","title":"Common variants in the sex hormone-binding globulin gene (SHBG) and polycystic ovary syndrome (PCOS) in Mediterranean women.","date":"2012","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23001781","citation_count":38,"is_preprint":false},{"pmid":"12785102","id":"PMC_12785102","title":"Mechanical response of single filamin A (ABP-280) molecules and its role in the actin cytoskeleton.","date":"2002","source":"Journal of muscle research and cell motility","url":"https://pubmed.ncbi.nlm.nih.gov/12785102","citation_count":37,"is_preprint":false},{"pmid":"1618927","id":"PMC_1618927","title":"Identification of a core motif that is recognized by three members of the HMG class of transcriptional regulators: IRE-ABP, SRY, and TCF-1 alpha.","date":"1992","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1618927","citation_count":37,"is_preprint":false},{"pmid":"16926175","id":"PMC_16926175","title":"Detection and quantification of 4-ABP adducts in DNA from bladder cancer patients.","date":"2006","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/16926175","citation_count":35,"is_preprint":false},{"pmid":"18269759","id":"PMC_18269759","title":"Rapid bursts of androgen-binding protein (Abp) gene duplication occurred independently in diverse mammals.","date":"2008","source":"BMC evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/18269759","citation_count":35,"is_preprint":false},{"pmid":"32054272","id":"PMC_32054272","title":"Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn's disease: an observational study.","date":"2020","source":"Revista espanola de enfermedades digestivas","url":"https://pubmed.ncbi.nlm.nih.gov/32054272","citation_count":34,"is_preprint":false},{"pmid":"7025773","id":"PMC_7025773","title":"Androgen transport proteins: physical properties, hormonal regulation, and possible mechanism of TeBG and ABP action.","date":"1981","source":"Archives of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/7025773","citation_count":33,"is_preprint":false},{"pmid":"15528874","id":"PMC_15528874","title":"Effects of combination treatment with losartan and trandolapril on office and ambulatory blood pressures in non-diabetic renal disease: a COOPERATE-ABP substudy.","date":"2004","source":"American journal of nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/15528874","citation_count":33,"is_preprint":false},{"pmid":"9408945","id":"PMC_9408945","title":"SHBG region of the anticoagulant cofactor protein S: secondary structure prediction, circular dichroism spectroscopy, and analysis of naturally occurring mutations.","date":"1997","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/9408945","citation_count":32,"is_preprint":false},{"pmid":"28077498","id":"PMC_28077498","title":"Modulation of SHBG binding to testosterone and estradiol by sex and morbid obesity.","date":"2017","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28077498","citation_count":31,"is_preprint":false},{"pmid":"168102","id":"PMC_168102","title":"Testicular androgen-binding protein (ABP): comparison of ABP in rabbit testis and epididymis with a similar androgen-binding protein (TeBG) in rabbit serum.","date":"1975","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/168102","citation_count":30,"is_preprint":false},{"pmid":"21752884","id":"PMC_21752884","title":"Circulating testosterone and SHBG concentrations are heritable in women: the Framingham Heart Study.","date":"2011","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21752884","citation_count":30,"is_preprint":false},{"pmid":"30922373","id":"PMC_30922373","title":"An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis.","date":"2019","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30922373","citation_count":29,"is_preprint":false},{"pmid":"12795612","id":"PMC_12795612","title":"Characterization of two forms of mouse salivary androgen-binding protein (ABP): implications for evolutionary relationships and ligand-binding function.","date":"2003","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12795612","citation_count":28,"is_preprint":false},{"pmid":"31793624","id":"PMC_31793624","title":"Serum SHBG Is Associated With the Development and Regression of Nonalcoholic Fatty Liver Disease: A Prospective Study.","date":"2020","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31793624","citation_count":28,"is_preprint":false},{"pmid":"11276089","id":"PMC_11276089","title":"Three-dimensional model of the SHBG-like region of anticoagulant protein S: new structure-function insights.","date":"2001","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/11276089","citation_count":28,"is_preprint":false},{"pmid":"24892637","id":"PMC_24892637","title":"Naturally occurring mutants inform SHBG structure and function.","date":"2014","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/24892637","citation_count":26,"is_preprint":false},{"pmid":"27576188","id":"PMC_27576188","title":"Effects of sex hormone-binding globulin (SHBG) on androgen bioactivity in vitro.","date":"2016","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27576188","citation_count":26,"is_preprint":false},{"pmid":"21193555","id":"PMC_21193555","title":"Cytoplasmic accumulation of incompletely glycosylated SHBG enhances androgen action in proximal tubule epithelial cells.","date":"2010","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/21193555","citation_count":26,"is_preprint":false},{"pmid":"16700002","id":"PMC_16700002","title":"Expression of androgen-binding protein (ABP) in human cardiac myocytes.","date":"2006","source":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/16700002","citation_count":25,"is_preprint":false},{"pmid":"1338724","id":"PMC_1338724","title":"Binding of sex-hormone-binding globulin (SHBG) to testicular membranes and solubilized receptors.","date":"1992","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/1338724","citation_count":25,"is_preprint":false},{"pmid":"562259","id":"PMC_562259","title":"Distribution of testosterone-estradiol binding globulin (TeBG) in the higher vertebrates.","date":"1977","source":"Endokrinologie","url":"https://pubmed.ncbi.nlm.nih.gov/562259","citation_count":25,"is_preprint":false},{"pmid":"26600064","id":"PMC_26600064","title":"Common Variants in the Sex Hormone-Binding Globulin (SHBG) Gene Influence SHBG Levels in Women with Polycystic Ovary Syndrome.","date":"2015","source":"Annals of nutrition & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/26600064","citation_count":24,"is_preprint":false},{"pmid":"11911837","id":"PMC_11911837","title":"Association of dopamine D(3) receptors with actin-binding protein 280 (ABP-280).","date":"2002","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11911837","citation_count":23,"is_preprint":false},{"pmid":"37221937","id":"PMC_37221937","title":"The Association between Inflammation, Testosterone and SHBG in men: A cross-sectional Multi-Ethnic Study of Atherosclerosis.","date":"2023","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37221937","citation_count":22,"is_preprint":false},{"pmid":"15566962","id":"PMC_15566962","title":"Phosphorylation of actin-binding protein (ABP-280; filamin) by tyrosine kinase p56lck modulates actin filament cross-linking.","date":"2004","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/15566962","citation_count":22,"is_preprint":false},{"pmid":"30972630","id":"PMC_30972630","title":"Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab.","date":"2019","source":"BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30972630","citation_count":22,"is_preprint":false},{"pmid":"17375264","id":"PMC_17375264","title":"Expression in Escherichia coli and purification of bioactive antibacterial peptide ABP-CM4 from the Chinese silk worm, Bombyx mori.","date":"2007","source":"Biotechnology letters","url":"https://pubmed.ncbi.nlm.nih.gov/17375264","citation_count":22,"is_preprint":false},{"pmid":"11163396","id":"PMC_11163396","title":"Identification of actin binding protein, ABP-280, as a binding partner of human Lnk adaptor protein.","date":"2000","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11163396","citation_count":22,"is_preprint":false},{"pmid":"15149727","id":"PMC_15149727","title":"Expression of sex hormone-binding globulin (SHBG) in human granulosa-lutein cells.","date":"2004","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15149727","citation_count":22,"is_preprint":false},{"pmid":"28947831","id":"PMC_28947831","title":"Resveratrol Increases Hepatic SHBG Expression through Human Constitutive Androstane Receptor: a new Contribution to the French Paradox.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28947831","citation_count":21,"is_preprint":false},{"pmid":"32078494","id":"PMC_32078494","title":"Circulating SHBG (Sex Hormone-Binding Globulin) and Risk of Ischemic Stroke: Findings From the WHI.","date":"2020","source":"Stroke","url":"https://pubmed.ncbi.nlm.nih.gov/32078494","citation_count":21,"is_preprint":false},{"pmid":"22915343","id":"PMC_22915343","title":"The ovarian response to standard gonadotrophin stimulation depends on FSHR, SHBG and CYP19 gene synergism.","date":"2012","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22915343","citation_count":20,"is_preprint":false},{"pmid":"33168491","id":"PMC_33168491","title":"Association between human SHBG gene polymorphisms and risk of PCOS: a meta-analysis.","date":"2020","source":"Reproductive biomedicine online","url":"https://pubmed.ncbi.nlm.nih.gov/33168491","citation_count":20,"is_preprint":false},{"pmid":"23410231","id":"PMC_23410231","title":"Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.","date":"2013","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/23410231","citation_count":20,"is_preprint":false},{"pmid":"28827052","id":"PMC_28827052","title":"Expression and characterization of the antimicrobial peptide ABP-dHC-cecropin A in the methylotrophic yeast Pichia pastoris.","date":"2017","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/28827052","citation_count":19,"is_preprint":false},{"pmid":"32216829","id":"PMC_32216829","title":"Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritis.","date":"2020","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32216829","citation_count":19,"is_preprint":false},{"pmid":"19679209","id":"PMC_19679209","title":"Effects of polymorphisms of the sex hormone-binding globulin (SHBG) gene on free estradiol and bone mineral density.","date":"2009","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/19679209","citation_count":19,"is_preprint":false},{"pmid":"23393169","id":"PMC_23393169","title":"Androgen receptor CAG repeat length is associated with body fat and serum SHBG in boys: a prospective cohort study.","date":"2013","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/23393169","citation_count":19,"is_preprint":false},{"pmid":"18322","id":"PMC_18322","title":"Testicular androgen binding protein (ABP) - a parameter of Sertoli cell secretory function.","date":"1975","source":"Current topics in molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/18322","citation_count":18,"is_preprint":false},{"pmid":"33808055","id":"PMC_33808055","title":"Sex Hormone Binding Globulin (SHBG) Mitigates ER Stress in Hepatocytes In Vitro and Ex Vivo.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/33808055","citation_count":18,"is_preprint":false},{"pmid":"33064664","id":"PMC_33064664","title":"The hepatic lipidome and HNF4α and SHBG expression in human liver.","date":"2020","source":"Endocrine connections","url":"https://pubmed.ncbi.nlm.nih.gov/33064664","citation_count":18,"is_preprint":false},{"pmid":"28347740","id":"PMC_28347740","title":"Selective cytotoxicity of the antibacterial peptide ABP-dHC-Cecropin A and its analog towards leukemia cells.","date":"2017","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28347740","citation_count":17,"is_preprint":false},{"pmid":"18056923","id":"PMC_18056923","title":"Associations of serum sex hormone binding globulin (SHBG) levels with SHBG gene polymorphisms in the CARDIA Male Hormone Study.","date":"2007","source":"American journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/18056923","citation_count":17,"is_preprint":false},{"pmid":"8976560","id":"PMC_8976560","title":"Direct evidence for the localization of the steroid-binding site of the plasma sex steroid-binding protein (SBP or SHBG) at the interface between the subunits.","date":"1996","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/8976560","citation_count":17,"is_preprint":false},{"pmid":"23718880","id":"PMC_23718880","title":"The role of retrotransposons in gene family expansions: insights from the mouse Abp gene family.","date":"2013","source":"BMC evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/23718880","citation_count":16,"is_preprint":false},{"pmid":"8274137","id":"PMC_8274137","title":"The amino acid sequence of the alpha subunit of mouse salivary androgen-binding protein (ABP), with a comparison to the partial sequence of the beta subunit and to other ligand-binding proteins.","date":"1993","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8274137","citation_count":16,"is_preprint":false},{"pmid":"25241628","id":"PMC_25241628","title":"Molecular structure, chemical synthesis, and antibacterial activity of ABP-dHC-cecropin A from drury (Hyphantria cunea).","date":"2014","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/25241628","citation_count":16,"is_preprint":false},{"pmid":"31203411","id":"PMC_31203411","title":"Bioactivation of the tobacco carcinogens 4-aminobiphenyl (4-ABP) and 2-amino-9H-pyrido[2,3-b]indole (AαC) in human bladder RT4 cells.","date":"2019","source":"Archives of toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/31203411","citation_count":15,"is_preprint":false},{"pmid":"27019440","id":"PMC_27019440","title":"Contribution of polymorphisms in ESR1, ESR2, FSHR, CYP19A1, SHBG, and NRIP1 genes to migraine susceptibility in Turkish population.","date":"2016","source":"Journal of genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27019440","citation_count":15,"is_preprint":false},{"pmid":"28159752","id":"PMC_28159752","title":"Studies of an Androgen-Binding Protein Knockout Corroborate a Role for Salivary ABP in Mouse Communication.","date":"2017","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28159752","citation_count":15,"is_preprint":false},{"pmid":"10414337","id":"PMC_10414337","title":"ABP: a novel AMPA receptor binding protein.","date":"1999","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/10414337","citation_count":14,"is_preprint":false},{"pmid":"32476063","id":"PMC_32476063","title":"Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product.","date":"2020","source":"Pharmaceutical research","url":"https://pubmed.ncbi.nlm.nih.gov/32476063","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54353,"output_tokens":5293,"usd":0.121227},"stage2":{"model":"claude-opus-4-6","input_tokens":8901,"output_tokens":2816,"usd":0.172357},"total_usd":0.293584,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1975,\n      \"finding\": \"Androgen-binding protein (ABP/SHBG) is produced by Sertoli cells in the testis, not by Leydig cells or germ cells; FSH stimulates its production and it is transported to the epididymis via efferent duct fluid.\",\n      \"method\": \"Testicular fractionation (tubule vs. interstitial preparations), efferent duct fluid vs. lymph measurements, gamma irradiation to ablate germ cells, hypophysectomy followed by FSH rescue\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vivo experiments replicated across conditions\",\n      \"pmids\": [\"1126559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1981,\n      \"finding\": \"SHBG (TeBG) functions as an androgen transport and carrier protein in plasma, and as androgen-binding protein (ABP) in the seminiferous tubule/epididymis compartment, with both serving to regulate androgen secretion, transport, and cellular absorption.\",\n      \"method\": \"Review of physical characterization studies (binding kinetics, gel filtration, sedimentation) and hormonal regulation experiments\",\n      \"journal\": \"Archives of andrology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — review synthesizing multiple binding and physicochemical characterization studies\",\n      \"pmids\": [\"7025773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"TeBG (SHBG)-bound testosterone and estradiol are efficiently cleared across the blood-tubular barrier of the testis and prostate cell membrane in vivo, indicating that TeBG-bound sex steroids (not just free hormone) are bioavailable to Sertoli and prostate cells; extravascular extraction of radiolabeled TeBG was 73–92% in testis and prostate respectively.\",\n      \"method\": \"In vivo arterial bolus injection of radiolabeled testosterone, estradiol, and TeBG in anesthetized rats; tissue extraction quantification\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — direct in vivo quantitative influx measurements with multiple tracers\",\n      \"pmids\": [\"3379140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"SHBG inhibits uptake of DHT into prostate carcinoma cells in a binding-capacity-dependent manner, but also stimulates DNA synthesis (thymidine incorporation) in these cells via a specific high-affinity cell membrane receptor for SHBG; this growth effect is enhanced by testosterone and abolished when SHBG is saturated with DHT. SHBG mRNA (1.9 and 2.8 kb) is expressed endogenously in prostate carcinoma cell lines.\",\n      \"method\": \"Radiolabeled DHT uptake assays, [3H]thymidine incorporation, Northern blot, radioligand binding (cell membrane receptor identification)\",\n      \"journal\": \"The Journal of steroid biochemistry and molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (binding, uptake, proliferation, mRNA) in a single study\",\n      \"pmids\": [\"1958578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"TeBG (SHBG) undergoes receptor-mediated endocytosis in human MCF-7 breast cancer cells: it binds to the plasma membrane, enters receptosomes, and traffics through multivesicular endosomes to lysosomes in the Golgi zone; uptake is temperature-dependent, saturable, and competable with unlabeled TeBG.\",\n      \"method\": \"Radiolabeled TeBG uptake assays, electron microscopy with TeBG-gold complexes, pronase surface release experiments, subcellular fractionation with lysosomal marker\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — electron microscopy with gold conjugates plus fractionation, multiple orthogonal methods in one study\",\n      \"pmids\": [\"1675988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"SHBG is a homodimer; the steroid-binding site is located at the interface between the two subunits. Dissociation in urea and renaturation reconstitutes dimers with normal steroid-binding affinity. A human-rabbit hybrid dimer demonstrates that only one face of the dimer determines specificity for estradiol binding, while the androgen-binding face is shared by both sides.\",\n      \"method\": \"Urea dissociation and renaturation, formation of human-rabbit hybrid dimers, radioligand binding (Kd determination for DHT and estradiol)\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution of native function from denatured subunits plus hybrid dimer experiment, mechanistically definitive\",\n      \"pmids\": [\"8976560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Sertoli cell-secreted ABP is endocytosed by germ cells via a clathrin-coated vesicle pathway; germ cells possess a single class of high-affinity binding sites for ABP (Kd ~0.78 nM for rat ABP, ~0.56 nM for human SHBG); internalized ABP stimulates secretion of specific spermatocyte proteins and, together with steroids, induces synthesis of new spermatocyte proteins.\",\n      \"method\": \"Radiolabeled ABP/SHBG binding and internalization, transmission electron microscopy, autoradiography, 2D-SDS-PAGE of secreted proteins, Scatchard analysis of membrane binding sites\",\n      \"journal\": \"The Journal of steroid biochemistry and molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (EM, autoradiography, binding kinetics, proteomic analysis) in one study\",\n      \"pmids\": [\"7626507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"SHBG binds to a specific, saturable, high-affinity receptor on rat testicular membranes (Kd 5×10⁻⁸ M at 37°C; capacity 30 pmol/mg protein); solubilization of the receptor increases binding capacity 5-fold and decreases affinity 10-fold; apparent molecular weight of the testicular SHBG receptor is ~174,000 Da.\",\n      \"method\": \"Radioligand binding to testicular membrane preparations, Scatchard analysis, gel filtration of solubilized receptor\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic binding characterization in membrane fractions with multiple parameters; single lab\",\n      \"pmids\": [\"1338724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The SHBG-like region of protein S (a structural homolog domain) is critical for its FV-dependent APC-cofactor activity in FVIIIa degradation; a protein S/Gas6 chimera in which the SHBG-like region was replaced by that of Gas6 lost FV-dependent APC-cofactor activity while retaining ~40–50% activity in FVa degradation.\",\n      \"method\": \"Recombinant chimeric protein construction and functional testing in plasma thrombin generation and FVIIIa degradation assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — domain-swap mutagenesis with direct functional reconstitution assays\",\n      \"pmids\": [\"9738926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The D327N (Asp327Asn) polymorphism in SHBG exon 8 delays SHBG half-life and is associated with higher circulating SHBG levels; the pentanucleotide (TAAAA)n repeat in the SHBG 5' UTR influences SHBG transcription in vitro and affects SHBG serum concentrations in a repeat-length-dependent manner (fewer repeats → higher SHBG).\",\n      \"method\": \"RFLP genotyping for D327N, GeneScan for TAAAA repeats, multivariate analysis of serum SHBG levels, luciferase reporter assays (cited in text for in vitro transcription effect)\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional polymorphism data combined with population genetics; D327N half-life effect from prior studies cited\",\n      \"pmids\": [\"14764814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SHBG interacts with a specific binding site on MCF-7 breast cancer cell membranes and activates a cAMP-dependent intracellular pathway that inhibits estradiol-mediated ERK activation and cell growth; cross-talk occurs at the MAP kinase level between the membrane-initiated SHBG pathway and the estradiol pathway.\",\n      \"method\": \"Cell membrane binding assays, cAMP measurement, ERK activation assays, cell proliferation/apoptosis assays in MCF-7 cells\",\n      \"journal\": \"Hormone and metabolic research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple signaling readouts in a single cell model; single lab\",\n      \"pmids\": [\"16700004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Incompletely glycosylated (lacking O-linked oligosaccharides and with incomplete N-glycosylation) SHBG accumulates within the cytoplasm of proximal tubule epithelial cells and enhances androgen uptake and sustained androgen receptor nuclear localization, thereby amplifying androgen-dependent gene expression long after steroid withdrawal.\",\n      \"method\": \"Western blotting of cellular vs. secreted SHBG, radiolabeled DHT sequestration assays, luciferase androgen reporter assay, RT-qPCR of endogenous androgen-regulated genes, transcriptome profiling, immunofluorescence of androgen receptor localization in mouse PCT cell line expressing human SHBG transgene\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — multiple orthogonal methods (biochemical, reporter, transcriptomic, imaging) in a mechanistically defined cellular system\",\n      \"pmids\": [\"21193555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TNFα reduces SHBG production in hepatocytes indirectly via NF-κB activation: NF-κB binds to the HNF-4α proximal promoter (which contains three NF-κB binding sites) and represses HNF-4α expression, which in turn reduces SHBG transcription. The human SHBG promoter itself is not directly regulated by NF-κB.\",\n      \"method\": \"Luciferase reporter assays with SHBG and HNF-4α promoter constructs, siRNA knockdown of NF-κB p65, p65 overexpression, chromatin immunoprecipitation (ChIP) for NF-κB binding to HNF-4α promoter in HepG2 cells\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — ChIP plus reporter assays plus siRNA/overexpression; multiple orthogonal mechanistic approaches in one study\",\n      \"pmids\": [\"22301786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Adiponectin increases hepatic SHBG production via AMPK activation, which reduces hepatic lipid content (decreasing ACC-driven lipogenesis, increasing ACOX/CPTI-driven fatty acid oxidation) and thereby increases HNF-4α levels; HNF-4α silencing blocks adiponectin-induced SHBG upregulation.\",\n      \"method\": \"HepG2 cell treatment with adiponectin, AMPK inhibition assays, siRNA knockdown of HNF-4α, lipogenesis/fatty acid oxidation enzyme mRNA/protein measurement, triglyceride and FFA quantification, correlation with human liver biopsies\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — siRNA rescue experiments plus pharmacological inhibition plus human liver biopsy correlation; multiple orthogonal approaches\",\n      \"pmids\": [\"24828613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The SHBG-like domain (and specifically its laminin G-type 1 subunit, residues Ser283–Val459) of protein S is required for binding to TFPI and enhancing TFPI-mediated inhibition of factor Xa; free protein S (not C4BP-bound) is needed for TFPI cofactor function.\",\n      \"method\": \"Domain-swap chimera screening (44 protein S variants), thrombin generation assay, FXa inhibition assays, surface plasmon resonance binding of protein S to TFPI\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — comprehensive domain-swap mutagenesis with SPR and functional assays; mechanistically definitive\",\n      \"pmids\": [\"24740810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Eight naturally occurring nonsynonymous SNPs in the N-terminal laminin G-like domain of SHBG alter its production or biochemical properties: O-linked glycosylation at Thr7 is disrupted (T7N), abnormal N-glycosylation limits secretion (G195E), three mutants (R135C, L165M, E176K) bind estradiol with abnormally high affinity, R135C has increased fibulin-2 interaction, two dimer-interface mutants (R123H, R123C) reduce DHT affinity while increasing relative estradiol affinity, and T48I is defective in calcium binding leading to dimerization defects and reduced steroid affinity (all restored by calcium).\",\n      \"method\": \"Site-directed mutagenesis, HepG2 cell expression and secretion assays, radioligand steroid-binding assays, calcium chelation/supplementation experiments, fibulin-2 binding assays\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with multiple biochemical functional readouts; single comprehensive study\",\n      \"pmids\": [\"24892637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Resveratrol increases hepatic SHBG production specifically through human constitutive androstane receptor (CAR), which binds to a direct repeat 1 (DR1) nuclear hormone receptor element in the human SHBG proximal promoter; this was confirmed in humanized SHBG/CAR transgenic mice and correlates with CAR mRNA in human liver biopsies.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) for CAR binding to SHBG promoter DR1 element, luciferase reporter assays, resveratrol treatment of HepG2 cells, humanized transgenic mouse experiments, human liver biopsy correlation\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — ChIP plus reporter assays plus in vivo transgenic validation; multiple orthogonal methods\",\n      \"pmids\": [\"28947831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SHBG mRNA and protein are expressed locally in human granulosa-lutein cells (GLC) of the ovary, demonstrating that SHBG is produced in this tissue beyond the liver and may have a paracrine role in follicular physiology.\",\n      \"method\": \"Immunohistochemistry on human GLC, RT-PCR for full-length SHBG mRNA in cultured and uncultured cells\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — localization by IHC and RT-PCR; single lab without functional mechanistic follow-up\",\n      \"pmids\": [\"15149727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SHBG mRNA and protein are expressed in human cardiac myocytes (in dilated cardiomyopathy biopsies), confirmed by immunocytochemistry on semithin sections, in situ hybridization, and SELDI-TOF mass spectrometry of affinity-purified myocardial extracts, suggesting a local paracrine role for SHBG in regulating steroid bioavailability in the heart.\",\n      \"method\": \"Immunocytochemistry, in situ hybridization, SELDI-TOF mass spectrometry\",\n      \"journal\": \"Hormone and metabolic research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — three orthogonal detection methods confirm expression; limited functional mechanistic follow-up\",\n      \"pmids\": [\"16700002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Exogenous SHBG protects palmitate-treated hepatocytes against ER stress by reducing expression of IRE1α, ATF6, CHOP, and BIP, and also regulates lipolytic gene expression in liver tissue ex vivo.\",\n      \"method\": \"Palmitate-treated HepG2 cells and ex vivo liver tissue culture with exogenous SHBG (50–100 nM), western blotting and RT-qPCR for ER stress markers\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and ex vivo experiments with multiple molecular markers; single lab, mechanistic pathway not fully defined\",\n      \"pmids\": [\"33808055\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SHBG binding capacity for testosterone and estradiol differs between sexes and obesity status: in men testosterone occupies most SHBG binding sites whereas estradiol binding is much lower; morbid obesity reduces SHBG levels and consequently testosterone (but not estradiol) binding, suggesting SHBG is a mixture of at least two functionally distinct hormone-binding globulins with different affinities for the two steroids.\",\n      \"method\": \"Western blotting of plasma SHBG protein, tritium-labeled testosterone and estradiol specific binding assays, ELISA for hormones in plasma from normal-weight and obese men and women\",\n      \"journal\": \"European journal of endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding assays with two steroid substrates across subject groups; single lab\",\n      \"pmids\": [\"28077498\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SHBG is a homodimeric glycoprotein (with the steroid-binding site formed at the dimer interface) produced primarily by hepatocytes under transcriptional control of HNF-4α (itself regulated by AMPK/adiponectin signaling, NF-κB/TNFα signaling, and the nuclear receptor CAR/resveratrol pathway) and by Sertoli cells in response to FSH; it circulates as a high-affinity carrier for androgens and estrogens, regulates their bioavailability, is taken into cells via a specific membrane receptor through receptor-mediated endocytosis, and—particularly in its incompletely glycosylated intracellular form—can sustain androgen receptor nuclear localization and gene activation; additionally, SHBG activates a cAMP-dependent membrane-initiated signaling cascade in estrogen-responsive cells that cross-talks with ERK to antagonize estradiol-driven proliferation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SHBG is a homodimeric glycoprotein that serves as the principal plasma carrier for androgens and estrogens, regulating their bioavailability to target tissues through both passive transport and active receptor-mediated endocytosis. The steroid-binding site resides at the dimer interface, with calcium required for proper dimerization and distinct binding determinants for androgens versus estradiol [PMID:8976560, PMID:24892637]. Hepatic SHBG transcription is driven by HNF-4α and modulated by AMPK/adiponectin signaling, TNFα/NF-κB-mediated HNF-4α repression, and the nuclear receptor CAR, while Sertoli cells produce it under FSH control for androgen delivery to germ cells [PMID:1126559, PMID:24828613, PMID:22301786, PMID:28947831]. Beyond passive steroid sequestration, SHBG activates a cAMP-dependent membrane signaling pathway that antagonizes estradiol-driven ERK activation and cell proliferation, and incompletely glycosylated intracellular SHBG sustains androgen receptor nuclear localization and amplifies androgen-dependent gene expression [PMID:16700004, PMID:21193555].\",\n  \"teleology\": [\n    {\n      \"year\": 1975,\n      \"claim\": \"Identifying SHBG/ABP as a Sertoli cell product under FSH control established that SHBG is not merely a passive plasma binder but an actively regulated secretory protein with a defined cellular origin in the testis.\",\n      \"evidence\": \"Testicular fractionation, hypophysectomy with FSH rescue, efferent duct fluid measurements in rat\",\n      \"pmids\": [\"1126559\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of FSH-stimulated transcription not defined\", \"Sertoli cell SHBG promoter elements unknown at this stage\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Demonstrating that SHBG-bound steroids are efficiently extracted by testis and prostate in vivo overturned the free-hormone hypothesis for these tissues, showing SHBG itself facilitates steroid delivery.\",\n      \"evidence\": \"Arterial bolus injection of radiolabeled TeBG/steroids with tissue extraction quantification in anesthetized rats\",\n      \"pmids\": [\"3379140\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the membrane receptor mediating SHBG-steroid uptake not determined\", \"Mechanism of transcapillary transport unclear\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Discovery of a specific high-affinity membrane receptor for SHBG on prostate and breast cancer cells, and demonstration of receptor-mediated endocytosis through clathrin-coated vesicles to lysosomes, established that SHBG signals and traffics as a ligand rather than acting solely as an extracellular carrier.\",\n      \"evidence\": \"Radioligand binding, electron microscopy with gold-conjugated TeBG, thymidine incorporation in prostate carcinoma cells; saturable endocytosis in MCF-7 cells\",\n      \"pmids\": [\"1958578\", \"1675988\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular identity of the SHBG membrane receptor remains unknown\", \"Downstream signaling mechanism not yet characterized\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Establishing that SHBG functions as a homodimer with the steroid-binding site at the dimer interface defined the structural basis for steroid recognition and explained species-specific ligand selectivity.\",\n      \"evidence\": \"Urea dissociation/renaturation, human-rabbit hybrid dimer formation with radioligand binding\",\n      \"pmids\": [\"8976560\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution crystal structure not yet available at this point\", \"Role of calcium in dimerization not yet recognized\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Showing that germ cells endocytose Sertoli-derived ABP/SHBG via clathrin-coated pits and that internalized ABP alters spermatocyte protein secretion demonstrated a paracrine signaling role for SHBG within the seminiferous epithelium.\",\n      \"evidence\": \"Radiolabeled ABP binding/internalization, TEM, 2D-SDS-PAGE of secreted spermatocyte proteins\",\n      \"pmids\": [\"7626507\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Intracellular fate of internalized ABP in germ cells not fully tracked\", \"Downstream signaling cascade in germ cells not identified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identifying that membrane-bound SHBG activates a cAMP pathway that cross-talks with ERK to oppose estradiol-driven proliferation revealed an active anti-proliferative signaling function independent of simple steroid sequestration.\",\n      \"evidence\": \"cAMP measurement, ERK activation assays, proliferation/apoptosis assays in MCF-7 breast cancer cells\",\n      \"pmids\": [\"16700004\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of the G-protein or receptor coupling SHBG to cAMP unknown\", \"Relevance in non-breast-cancer estrogen-responsive tissues not tested\", \"Single lab finding\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating that incompletely glycosylated intracellular SHBG sequesters androgens and sustains androgen receptor nuclear localization established a cell-autonomous amplification mechanism for androgen signaling distinct from extracellular carrier function.\",\n      \"evidence\": \"Radiolabeled DHT sequestration, androgen-responsive reporter and endogenous gene assays, immunofluorescence of AR localization in mouse PCT cells expressing human SHBG transgene\",\n      \"pmids\": [\"21193555\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether intracellular SHBG acts similarly in prostate cancer cells in vivo is untested\", \"Glycosylation site(s) responsible for intracellular retention not mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Elucidating that TNFα suppresses SHBG via NF-κB-mediated repression of HNF-4α (not direct SHBG promoter targeting) explained how inflammation reduces circulating SHBG and linked metabolic syndrome to sex steroid bioavailability.\",\n      \"evidence\": \"ChIP for NF-κB on HNF-4α promoter, siRNA knockdown and p65 overexpression, luciferase reporters in HepG2 cells\",\n      \"pmids\": [\"22301786\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other inflammatory cytokines use the same HNF-4α-dependent route is unknown\", \"In vivo validation in hepatocyte-specific knockout models lacking\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identifying adiponectin/AMPK as an upstream activator of SHBG via HNF-4α through reduced hepatic lipid content connected energy-sensing pathways to sex steroid regulation, while comprehensive mutagenesis of naturally occurring SHBG variants revealed how specific residues govern glycosylation, calcium-dependent dimerization, and differential steroid affinity.\",\n      \"evidence\": \"Adiponectin treatment of HepG2 cells with AMPK inhibition and HNF-4α siRNA; site-directed mutagenesis of eight SNPs with binding, secretion, and calcium-dependence assays\",\n      \"pmids\": [\"24828613\", \"24892637\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for how hepatic lipid content controls HNF-4α levels is incompletely defined\", \"Population-level functional impact of rare SHBG missense variants on disease risk not established\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating that the nuclear receptor CAR binds a DR1 element in the SHBG promoter and mediates resveratrol-induced SHBG expression identified a druggable transcriptional regulator of SHBG and was validated in humanized transgenic mice.\",\n      \"evidence\": \"ChIP for CAR on SHBG promoter, luciferase reporters, resveratrol treatment in HepG2 cells and humanized SHBG/CAR transgenic mice, human liver biopsy correlation\",\n      \"pmids\": [\"28947831\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CAR agonists beyond resveratrol regulate SHBG in humans is untested\", \"Relative contribution of CAR vs. HNF-4α to basal SHBG expression not quantified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular identity of the membrane receptor that mediates SHBG binding, endocytosis, and cAMP signaling remains unknown, preventing a complete mechanistic model of SHBG's cell-surface signaling and steroid-delivery functions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"SHBG membrane receptor gene not cloned or identified\", \"Structural basis of SHBG-receptor interaction undefined\", \"Whether intracellular SHBG and membrane signaling converge on shared downstream targets is unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [1, 5, 15, 20]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [0, 1, 2, 6]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [3, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 1, 2, 5, 20]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 4, 10]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 10, 11]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [12, 13, 16]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 2, 6]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [13, 19]}\n    ],\n    \"complexes\": [\n      \"SHBG homodimer\"\n    ],\n    \"partners\": [\n      \"HNF4A\",\n      \"NR1I3\",\n      \"FBLN2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}